搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
mskcc.org
9 小时
MSK Doctor Discusses Magnesium’s Health Benefits: What Cancer Patients Should Know
Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers ...
14 小时
Creating a more accurate model of inflammatory bowel disease
A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, ...
Business Wire
3 天
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
Targeted Oncology
3 天
Approved Therapies Considered for Patients With Graft-Vs-Host Disease
Noah M. Merin, MD, PhD, assistant professor at Cedars-Sinai Medicine and medical director of the Hematology and Cellular ...
The American Journal of Managed Care
3 天
First Schizophrenia Treatment Approved in Decades Targets Cholinergic Receptors
Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...
The American Journal of Managed Care
3 天
FDA Approves Dupilumab as First Biologic Treatment for COPD
The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...
3 天
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients ...
Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...
3 天
Some people insist the Tijuana River is poisoning them: Officials disagree
The Tijuana River should not be flowing this time of year. But throughout the dry season, it has—delivering millions of ...
4 天
on MSN
FDA approves 1st new drug to treat schizophrenia in more than 30 years
This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a ...
Business Wire
5 天
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA ...
Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA® (voxelotor) for the treatment ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈